Fibroblast growth factor and nucleic acids encoding same
US7056885B1 · kind B1 · utility
5Cited by
1References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 3, 2000 |
| Grant date | Jun 6, 2006 |
| Priority date | — |
| Expiry date | Dec 30, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides FGF-CX polypeptides and polynucleotides, and antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, or fragment of the FGF-CX polypeptide, polynucleotide or antibody. The invention additionally provides methods of use for the FGF-CX polypeptide, polynucleotide and antibody.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.